Characterisation of Drug Nanocarriers | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Evgeny K Apartsin
B01=Ivana Vinkovi Vrek
B01=Jesus M de la Fuente
Category1=Non-Fiction
Category=MMG
Category=PSB
Category=TBN
Category=TCB
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Characterisation of Drug Nanocarriers

English

Nanotechnology has the potential to solve many unmet, urgent healthcare requirements. However, bridging the translational gap between lab and clinic for nanodrugs is still challenging, and there is limited guidance on regulatory-relevant information and approaches. The main aim of this book is to provide guidance on characterization of drug carrier properties and efficacy required for regulatory acceptance of nanomaterials for their use in medicine.This book provides a comprehensive overview of drug loading and delivery nanocarriers, including their characteristics, methodologies and techniques to evaluate the association and interaction of the drug with different nanocarriers.

See more
Current price €202.34
Original price €212.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Evgeny K ApartsinB01=Ivana Vinkovi VrekB01=Jesus M de la FuenteCategory1=Non-FictionCategory=MMGCategory=PSBCategory=TBNCategory=TCBCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 18 Dec 2024

Product Details
  • Dimensions: 156 x 234mm
  • Publication Date: 18 Dec 2024
  • Publisher: Royal Society of Chemistry
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781837670994

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept